Summit convened by:

Center for Biosecurity of UPMC

Canadian Policy Research Network

Center for Science Technology and Security Policy at AAAS

National Consortium for the Study of Terrorism and Responsed to Terror

Sarah Landry

Prior to her job with GlaxoSmithKline (GSK), Ms. Landry served as Associate Director of Policy in the National Vaccine Program Office (NVPO). The NVPO provides a leadership role in working with HHS and other federal agencies, nongovernmental offices and organizations, states, municipalities, health care providers, and industry to ensure a coordinated national vaccine effort. As Associate Director of Policy, she worked closely with other agencies to ensure that department priorities and policies regarding vaccine issues are consistently achieved and helped coordinate the development of the National Pandemic Influenza Plan. In addition, she co-chaired the cross-agency HHS Pandemic Influenza Communications Taskforce and was responsible for coordinating the development of a strategic communications and public engagement plan.

Previously, Ms. Landry worked in communication and science policy at NIAID for 12 years and gained experience in HIV/AIDS, global health, vaccine safety, emerging infectious diseases, and biodefense research.  Her experience in HIV started with the early placebo-controlled studies of AZT and moved into mother-to-infant transmission and vaccine prevention outreach. Ms. Landry later built on this experience when she transitioned into emerging infectious disease and global health. She developed several strategic planning documents in areas such as genomics, malaria, tuberculosis, and biodefense, for which she received recognition by the government and associations. In addition, Ms. Landry was the editor of the 20th edition of the Jordan Report, which is recognized as the authoritative guide on the state of vaccine research.

She has received numerous awards recognizing her contributions to HHS. In 2004 she received the Secretary’s Superior Service Award for her work during the influenza vaccine shortage. She received two Secretary Awards in 2003, one for the work in disseminating information related to malaria genome sequencing activities and the other for biodefense communication activities. In 2002, she received an NIH Director’s Award for contributions to biodefense research. In 2000, she received an NIH Director’s award for dissemination of findings resulting from NIAID-supported nevirapine studies, and in 1999 she received an NIH Merit Award for exceptional leadership and initiative in the dissemination of HIV/AIDS scientific information through public liaison and education outreach. In 2000, Time Magazine recognized the AIDS Vaccine Website Ms. Landry developed as on of the top ten best health sites. She has received several awards for her publications.

Ms. Landry has a Master of Arts degree in Science Writing from John Hopkins University. Her graduate thesis described new trends in infectious disease and included pieces on genomic sequencing, edible vaccines, polio eradication, antibiotic resistance in the food chain, and the link between Chlamydia pneumoniae infection and heart disease.